BTAI Similar Chart Price Prediction
The price of BTAI is predicted to go up -25.56%, based on the high correlation periods with LXU. The similarity of these two price pattern on the periods is 97.67%.
BTAI
LXU
Down: -25.56%Similarity: 97.67%
BTAI Revenue Forecast
BTAI EPS Forecast
BTAI FAQs
What is BTAI revenue forecast for next quarter？
BTAI Analyst's Forecast
Geoff Meacham
B of A Securities
Strong Buy → Sell
2025-01-07
Price Target
$7 → $0.25
Downside
-46.76%
BofA analyst Alec Stranahan downgraded BioXcel Therapeutics to Underperform from Buy with a price target of 25c, down from $7. The firm cites an "uncertain" agitation market opportunity, "lingering regulatory overhangs," and BioXcel's thinning cash position. More broadly for the sector, while political and rate uncertainty continues to be an overhang, the firm views the health of the Biopharma sector as "markedly improved from 2022 lows."
Sumant Kulkarni
Canaccord Genuity
Strong Buy
2025-01-06
Price Target
$7 → $5
Upside
+787%
